Who Paid My Doc
TEG6s HEMOSTASIS SYSTEM
Device Devices
PDI 30812747018351
General payments
$811,820
Research payments
$5,418,939
Through program year 2025, $811,820 in general payments and $5,418,939 in research payments were reported against TEG6s HEMOSTASIS SYSTEM (Devices).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
10 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $248,211 | 2,063 |
| 2025 | Research | $1,327,247 | 79 |
| 2024 | General | $157,528 | 1,645 |
| 2024 | Research | $570,399 | 96 |
| 2023 | General | $176,673 | 1,421 |
| 2023 | Research | $1,046,563 | 106 |
| 2022 | General | $134,562 | 725 |
| 2022 | Research | $1,889,361 | 140 |
| 2021 | General | $94,846 | 343 |
| 2021 | Research | $585,369 | 85 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 75 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 49 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
6,197 general · 506 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.